A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome

NCT05946941 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

774

Enrollment

INDUSTRY

Sponsor class

Conditions

Sjögren's Syndrome

Interventions

DRUG: Deucravacitinib
OTHER: Placebo

Sponsor

Bristol-Myers Squibb